Laddar...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Sparad:
| I publikationen: | Genome Med |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824555/ https://ncbi.nlm.nih.gov/pubmed/29471874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0524-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|